New York, NY -- (ReleaseWire) -- 04/09/2013 --Rite Aid Corporation (NYSE:RAD) announced sales results for March. For the four weeks ended March 30, 2013, same store sales decreased 2.0 percent over the prior-year period. March front-end same store sales increased 3.8 percent, with 3.0 percent of the increase attributable to a shift in the timing of Easter, which fell on March 31 this year compared to April 8 last year.

Pharmacy same store sales, which included an approximate 566 basis points negative impact from new generic introductions, decreased 4.5 percent. Prescription count at comparable stores increased 0.3 percent over the prior-year period.

Total drugstore sales for the four-week period decreased 2.5 percent to $1.939 billion compared to $1.989 billion for the same period last year. Prescription sales accounted for 67.6 percent of drugstore sales, and third party prescription sales represented 97.0 percent of pharmacy sales.

Find out where RAD could be headed here:
http://www.wallstreetreport.net/market-scan/?symbol=RAD

VelocityShares Daily Inverse VIX Short Term ETN (NYSE:XIV) traded at $ 24 in the last session, which is +0.63 (2.70%). The stock has a Range of 23.23 - 24.04. The stock has a 52 week low and high of 8.07 - 24.17 respectively. The stock has a Market Cap of 437.91M. The stock traded a volume of 1.5M.

The investment seeks to replicate, net of expenses, the inverse of the daily performance of the S&P 500 VIX Short-Term Futures index. The index was designed to provide investors with exposure to one or more maturities of futures contracts on the VIX, which reflects implied volatility of the S&P 500 Index at various points along the volatility forward curve.

Find out if XIV could maintain the momentum in the upcoming trading sessions here: http://www.wallstreetreport.net/market-scan/?symbol=XIV

About WallStreetReport.net
WallStreetReport.net issues momentum alerts on stocks that can provide gains to day traders. WallStreetReport.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. WallStreetReport.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.Through a vast network of IR professionals WallStreetReport.net is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. Gain an Edge by joining the WallStreetReport.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors to be part of the Free VIP membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.WallStreetReport.net

Disclosure
WallStreetReport.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetreport.Net website, for complete risks and disclosures.

BlueLys, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.

For full disclaimer visit: http://www.wallstreetreport.net/disclaimer-2/

Contact Info:
Michael Baine
WALL STREET REPORT
info@WallStreetReport.net
347-905-5009